September 21, 2026

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 26.5% Potential Upside

Investors looking for opportunities in the healthcare sector should turn their attention to The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the medical care..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Challenges in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a formidable player in the healthcare sector, has carved a niche for itself in the medical devices industry. Headquartered in Hercules,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Look at Its 14.36% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is a rapidly growing player in the biotechnology sector, renowned for its focus on genetic medicines addressing diseases with high unmet..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Biotech with Strong Revenue Growth and Strategic Collaborations

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is making waves with its innovative approaches to oncology treatments. Based in Alameda, California, Exelixis..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Potential 12.99% Upside Beckons Investors in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector known for its comprehensive eye health solutions, is drawing attention from investors with a..

Ionis Pharmaceuticals, Inc. (IONS): Investor Outlook on an 88.61% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in RNA-targeted therapies, is catching the attention of investors with its sizable potential upside of 88.61%. This commercial-stage biotechnology..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with a 7.15% Potential Upside

Lantheus Holdings, Inc. (LNTH), a formidable player in the healthcare sector, stands out in the niche of specialty and generic drug manufacturing. With a market capitalization..

Nuvalent, Inc. (NUVL) Stock Analysis: Navigating the Biotech Landscape with a Clinical Focus

Nuvalent, Inc. (NASDAQ: NUVL) has carved a niche in the promising and challenging field of biotechnology, specifically targeting cancer therapies. Despite its currently stable stock price..

Quest Diagnostics (DGX) Stock Analysis: Navigating the Diagnostic Giant’s Investment Landscape

Quest Diagnostics Incorporated (NYSE: DGX) stands out in the healthcare sector as a formidable player within the Diagnostics & Research industry. With a robust market capitalization..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Complex Terrain of Healthcare Innovation

Tempus AI, Inc. (NASDAQ: TEM), a pioneering entity in the healthcare technology sector, continues to chart an intriguing path in the health information services industry. With..

Cardinal Health, Inc. (CAH) Stock Analysis: A 20% Upside Potential Beckons Healthcare Investors

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the medical distribution industry, presents a compelling opportunity for investors, with a potential upside of over 20%..

Elanco Animal Health (ELAN) Stock Analysis: Unveiling 39% Upside Potential in the Thriving Animal Health Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands out in the bustling healthcare sector as a key player in the animal health industry, offering innovative solutions for..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth in Healthcare with Impressive Revenue Expansion

Medpace Holdings, Inc. (NASDAQ: MEDP) is making waves in the healthcare sector with its robust revenue growth and strong market presence. As a key player in..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: 50% Upside Potential Amid Steady Revenue Growth

For investors seeking resilient opportunities in the healthcare sector, Prestige Consumer Healthcare Inc. (PBH) presents a compelling case. This Tarrytown, New York-based company, with a market..

BrightSpring Health Services, I (BTSG) Stock Analysis: Strong Buy Ratings Signal a 39% Upside Potential

BrightSpring Health Services, I (BTSG), a prominent player in the Health Information Services industry, is capturing investor attention with its significant growth potential. Headquartered in Louisville,..

Guardant Health, Inc. (GH) Stock Analysis: A Strong Buy with 9% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a key player in the diagnostics and research industry within the healthcare sector, is making waves with its innovative approach to..

HCA Healthcare, Inc. (HCA) Stock Analysis: Potential Upside and Strategic Insights for Investors

HCA Healthcare, Inc. (NYSE: HCA), a titan in the U.S. healthcare sector, commands a significant presence in the medical care facilities industry. With a market capitalization..

Waystar Holding Corp. (WAY): Investor Outlook on a Healthcare Tech Leader with 30% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY), a prominent player in the healthcare technology space, is capturing the attention of investors with its innovative solutions and promising financial..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook on a Biotech Powerhouse with 27.57% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stands out in the biotechnology sector, with its focus on developing innovative therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The company’s flagship..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Promising 37% Upside Potential Amidst Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a leading player in the biotechnology sector focusing on central nervous system (CNS) disorders, is capturing significant attention from investors. With..

Search

Funds

September 21, 2026

Search

Funds

September 21, 2026

FTSE 100

Funds